UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

English Journal

Efficient Reprogramming of Human Cord Blood CD34(+) Cells Into Induced Pluripotent Stem Cells With OCT4 and SOX2 Alone.

Meng X, Neises A, Su RJ, Payne KJ, Ritter L, Gridley DS, Wang J, Sheng M, William Lau KH, Baylink DJ, Zhang XB.SourceDivision of Regenerative Medicine MC1528B, Department of Medicine, Loma Linda University, Loma Linda, California, USA.
Molecular therapy : the journal of the American Society of Gene Therapy.Mol Ther.2011 Nov 22. doi: 10.1038/mt.2011.258. [Epub ahead of print]
The reprogramming of cord blood (CB) cells into induced pluripotent stem cells (iPSCs) has potential applications in regenerative medicine by converting CB banks into iPSC banks for allogeneic cell replacement therapy. Therefore, further investigation into novel approaches for efficient reprogrammin
PMID 22108860

Braoudaki M, Tzortzatou-Stathopoulou F.SourceUniversity Research Institute for the Study and Treatment of Childhood Genetic and Malignant Diseases, University of Athens, Aghia Sophia Children's Hospital, Athens, Greece. mbraouda@yahoo.co.uk.
Journal of infection in developing countries.J Infect Dev Ctries.2011 Nov 15;5(11):751-8.
Retroviral infections are considered important risk factors for cancer development in humans since approximately 15-20% of cancer worldwide is caused by an infectious agent. This report discusses the most established oncogenic retroviruses, including human immunodeficiency virus (HIV), human T-cell
PMID 22112727

Pathogenicity of a Mutant Friend Spleen Focus-Forming Virus Encoding an Env-Like Membrane Glycoprotein (gp55) with Substitution by x Xenotropic Murine Leukemia Virus Env gp70 Sequence

A Mouse Erythroleukemia Cell Line Possessing Friend Spleen Focus-forming Virus gp55 Transgene and Temperature-sensitive Mutant p53 Gene

XU Xin,YAMAMURA Yasuko,TSUKADA Teruyo,YOSHIDA Mitsuaki A.,SENDA Hisato,NAGAYOSHI Mariko,IKEUCHI Tatsuro,IKAWA Yoji
Japanese journal of cancer research : gann 86(3), 284-291, 1995-03-31
NAID 10008067551